The QualityStocks Daily Monday, August 26th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(PRTG) $6.0000 +122.20%

360 Wall Street(SQNS) $1.1500 +111.71%

MarketClub Analysis(MNTS) $1.0500 +82.39%

The QualityStocks Daily Stock List

AB International Group (ABQQ)

QualityStocks, MarketClub Analysis and MarketBeat reported earlier on AB International Group (ABQQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AB International Group Corp. (OTCQB: ABQQ) is a development-stage firm that is engaged in developing a social video sharing platform and smartphone video mix application in the People’s Republic of China.

The firm has its headquarters in New York and was incorporated in 2013, on July 29th. It operates in the consumer discretionary sector under the retail-discretionary sub industry.

The enterprise offers a platform dubbed Ai Bia Quan Qiu, which provides matching services to merchants who are sourcing for actors to perform at advertising events. It also acquires and distributes music, TV show and movies. The intellectual property investment and licensing firm is also involved in the sale of used automobile vehicles to consumers in Krygyzstan.

The company has a patent license to a video synthesis and release system for mobile communications equipment and a video streaming service. Its services are distributed and marketed globally under www.abqq.tv and feature drama series, tv shows and Chinese movies whose exclusive rights have been acquired by the company. As a new and profitable revenue stream that was recently launched, the video streaming service is expected to bring in a lot of revenue.

The firm recently reported financial results for their first quarter of 2021, which show that revenue and gross profits grew by over 400% and 350% respectively, in comparison with the same period in the previous year. Their recently launched streaming service and the acquisition of more movie broadcast rights will boost investments into the firm and increase their revenue, as well as boost their popularity and extend their consumer reach.

AB International Group (ABQQ), closed Monday's trading session at $0.001, up 42.8571%, on 178,884,590 volume. The average volume for the last 3 months is 65.225M and the stock's 52-week low/high is $0.0001/$0.0035.

Hiru Corporation (HIRU)

OTCReporter, Mina Mar Marketing Group, QualityStocks, Willy Wizard, Stockpalooza, Penny Invest, PennyOmega, CRWEWallStreet, StockHotTips, BestOtc, CoolPennyStocks, DrStockPick, CRWEFinance, PennyToBuck, BullRally, HotOTC, Stock Rich, StockEgg, CRWEPicks, OTCPicks, MarketClub Analysis, Epic Stock Picks, StockRockandRoll, Penny Stock 101, PennyStockLocks, Stocks Gone Wild, Wise Alerts, MarketClub Options, Micro Cap Momentum, HEROSTOCKS, Purely Penny Stocks, Topgun stockpicks, Penny stock Profitz, The Stock Psycho, Stocktwiter, Stock Exploder, Bull Warrior Stocks, StocksAlarm, StockMister, Penny Stocks Pushers, SmarTrend Newsletters, Penny Picks, Greenbackers, Pumps and Dumps, PennyStockRumors.net, Light Speed Stocks, Wise Penny Stocks, BeatPennyStocks and Damn Good Penny Picks reported earlier on Hiru Corporation (HIRU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hiru Corporation (OTC: HIRU) is engaged in the production of Chinese herbs for China’s naturopathic industry.

The firm has its headquarters in Phoenix, Arizona and was incorporated in 1989. Prior to its name change in November 2008, the firm was known as Phoenix Restaurant Group Inc.

The company distributes and sells its pharmaceuticals, dietary and herbal supplements, beauty and health products and other healthcare products via regional distributors, as well as directly to pharmacies, clinics and hospitals in China.

The enterprise manufactures herbal supplements that contain ginseng and an additional 120 extracts which are also utilized in traditional Chinese medicine. It also provides consumers in the state of Arizona with bottled water and bagged ice. In addition, it is involved in the development, manufacture and commercialization of various veterinary products for the agricultural market in China via its Jiangxi Shuangshi AHP Co. subsidiary whose objective is to protect both human and animal health. The enterprise is focused on expanding its research and development and is planning to introduce veterinary solutions and drugs to the Chinese market via its subsidiary. To improve the health of livestock, the firm produces premixes, loose powders, feed additives, liquid disinfectants, oral liquids, injections, volume injections and other injectables.

The company is focused on meeting all of its consumers’ demands having recently appointed a new CEO. This appointment will help bring in a lot of investment opportunities as well as business into the firm, which are bound to have a positive effect on the company’s growth.

Hiru Corporation (HIRU), closed Monday's trading session at $0.0036, up 28.5714%, on 39,927,042 volume. The average volume for the last 3 months is 776,873 and the stock's 52-week low/high is $0.0003/$0.0051.

Elite Pharmaceuticals (ELTP)

QualityStocks, Stockpalooza, PennyTrader Publisher, PennyStocks24, OTCPicks, MarketBeat, Real Pennies, Marketbeat.com, PennyStock MarketBulls, MadPennyStocks, SmarTrend Newsletters, Capital Equity Report, MarketMovingTrends, PennyInvest, Greenbackers, First Penny Picks, RagingStock Bull, OTCBB Journal, TopPennyStockMovers, StockEgg, Stock Analyzer, Top Stock Picks, Pennybuster, MarketClub Analysis, StocksImpossible, The Daily Market Alert, TheMicrocapNews, HotStockChat, HotOTC, FeedBlitz, Money Wealth Matters, DividendStocks, CRWEPicks, CoolPennyStocks, Wise Alerts, Buzz Stocks, BullRally, Beacon Equity Research, GoldminePennyStocks, Stock Preacher, SmallCap Network, SmallCapVoice, Pumps and Dumps, Promotion Stock Secrets, Planet Penny Stocks, PennyStockVille, Stock Fortune Teller, StockRich, WiseAlerts, MicrocapVoice, Alternative Energy, Penny Stock Rumble, Penny Pick Finders, Penny Invest, StockOnion, OTC Advisors, SecretStockPromo and PennyStockProphet reported earlier on Elite Pharmaceuticals (ELTP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Elite Pharmaceuticals Inc. (OTCQB: ELTP) is a pharmaceutical firm that is focused on conducting research on, developing, manufacturing and licensing drug delivery products and systems.

The firm’s headquarters are in the state of New Jersey, United States and was incorporated in 1997, on October 1st. It operates as part of the healthcare industry, under the biotech and pharma sub-industry. The firm serves consumers around the globe.

The company is party to a strategic marketing alliance with Lannett Company Inc. and Glenmark Pharmaceuticals Inc. It is also party to a development and license agreement with SunGen Pharma LLC.; and a manufacturing and license agreement with Epic Pharma LLC. The company operates through the New Drug applications for branded and generic products.

The enterprise’s products include Isradipine capsules for cardiovascular ailments; Naltrexone tablets for pain management; Phendimetrazine Tartrate tablets for bariatrics; and HydromorphoneHCl tablets for pain. It also offers Methadone HCl tablets for pain; Trimipramine Maleate Immediate Release antidepressant capsules; Amphetamine sulfate immediate release, Dextroamphetamine sulfate and Dextroamphetamine saccharate tablets for central nervous system diseases. In addition to this, the enterprise manufactures controlled-release products on a contract basis for 3rd parties, in the areas of infection, bariatric, allergy and pain. The enterprise is also focused on the development of a range of abuse deterrent opioid products.

The firm recently released it latest financial results for the year 2021, which show increases in its revenues and profits. Currently, it is focused on diversifying its products in order to stabilize the firm and support its growth.

Elite Pharmaceuticals (ELTP), closed Monday's trading session at $0.2392, up 19.5402%, on 4,283,279 volume. The average volume for the last 3 months is 88,205 and the stock's 52-week low/high is $0.05605/$0.2409.

Sitka Gold (SITKF)

We reported earlier on Sitka Gold (SITKF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sitka Gold Corp (OTCQB: SITKF) (CNSX: SIG) (FRA: 1RF) is a mineral exploration firm focused on exploring for minerals at resource properties in the U.S. and Canada.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2015, on January 13th. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.

The company explores for gold, zinc, silver, and copper deposits. It owns interests in the OGI property, which comprises of 99 quartz mining claims located in Dawson City, Yukon; the Coppermine River project, which covers an area of about 50,000 hectares and is located in Nunavut; the RC Gold property, which comprises of 1,891 claims that cover an area of approximately 37,600 hectares situated in Yukon; and the Alpha Gold property, which includes 293 claims that covers an area of approximately 4780 acres situated in Eureka County, Nevada. The company also holds an option to acquire a 100% interest in the Burro Creek property, which covers an area of about 750 hectares. This property includes 4 patented mineral claims and 35 surrounding lode mineral claims located in the Mohave County, Arizona. It also holds an option to acquire interest in the Barney Ridge property situated to the east of Dawson City, Yukon. In addition to this, it holds a 100% interest in the Mahtin property, which comprises 1,447 quartz mining claims that cover an area of 30,242 hectares located in Yukon territory; and the Clear Creek Gold property, located to the east of Dawson City, Yukon.

The firm, which recently drilled over 1.34 million ounces of gold in two major deposits, is focused on accelerating exploration efforts at its properties as well as furthering development. This may positively influence shareholder value.

Sitka Gold (SITKF), closed Monday's trading session at $0.161, up 13.3803%, on 1,007,001 volume. The average volume for the last 3 months is 1.968M and the stock's 52-week low/high is $0.0901/$0.194.

Tantech Holdings (TANH)

QualityStocks, BUYINS.NET, TradersPro, The Online Investor, StreetInsider, INO.com Market Report, TraderPower, MarketClub Analysis, StockMarketWatch, Premium Stock Alerts, MarketBeat, InvestorPlace and Investing Futures reported earlier on Tantech Holdings (TANH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tantech Holdings Ltd (NASDAQ: TANH) is focused on the development and manufacture of bamboo-based charcoal products for various applications, which include cleaning, agricultural, purification, heating, household cooking and industrial energy.

The firm has its headquarters in Lishui, the People’s Republic of China and was incorporated in 2001, on November 19th by Zheng Yu Wang. The firm serves consumers across the globe, with a focus on China.

The company operates through the Electric vehicle, Trading and Consumer product segments. The electric vehicle segment is focused on the provision of electric control systems for electric cars, auto parts, Li-ion batteries and solar cells. The trading segment is focused on the exportation of charcoal products. On the other hand, the consumer product segment offers barbecue charcoal, deodorization and purification products and cleaning products developed for the domestic market. These products are sold under the Charcoal Doctor brand.

The enterprise’s other products include a liquid byproduct that can be used in fertilizers, toilet cleaners, specialized soaps, lotions, detergents and disinfectants known as bamboo vinegar. This byproduct can also be used in different agricultural applications. In addition to this, the enterprise is also involved in the development and sale of specialty electric vehicles like funeral cars, special emergency vehicles, electric cleaning cars and brushless cleaning cars, as well as electric logistics cars and electric buses.

The firm recently reported its latest financial results for the first half of 2021, with its CEO noting that the firm is focused on expanding into the specialty vehicle market by shifting its business from being engaged in consumer product sales solely.

Tantech Holdings (TANH), closed Monday's trading session at $0.1544, up 11.0791%, on 10,018,459 volume. The average volume for the last 3 months is 230,255 and the stock's 52-week low/high is $0.1211/$3.94.

Kraken Robotics (KRKNF)

QualityStocks, Trades Of The Day, Trading Concepts, Planet MicroCap, MarketBeat, InvestorPlace and Daily Trade Alert reported earlier on Kraken Robotics (KRKNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kraken Robotics Inc. (OTCQB: KRKNF) (CVE: PNG) (FRA: 2KQ) is a marine technology firm that is focused on designing, manufacturing and selling software-centric batteries, sensors and underwater robotic systems for unmanned underwater vehicles for commercial and military applications.

The firm has its headquarters in Mount Pearl, Canada and was incorporated in 2008, on May 14th. Prior to its name change, the firm was known as Kraken Solar Inc. It operates as part of the scientific and technical instruments industry, under the technology sector. The firm has seven companies in its corporate family and primarily serves consumers in North America.

The company operates through the Power, Sensors and Platforms segments. The power segment comprises of sub-sea equipment like thrusters, drives and batteries. On the other hand, the sensors and platforms segment is focused on services for marine laser and sonar scanner sensor equipment and marine vehicle platforms. It has operations in the United States, Canada and Europe.

The enterprise’s products include an underwater laser imaging system dubbed SeaVision; and, a configurable miniature interferometric synthetic aperture sonar known as AquaPix. It also offers a hovering autonomous underwater vehicle known as Thunderfish; a towed underwater vehicle for high resolution seabed mapping and high speed operation dubbed Katfish; and a removable data storage module known as DataPod for marine applications.

The firm was recently awarded a million dollar contract by a defense industry customer, which brings in significant revenues and opens the firm up to more growth and investment opportunities. This will also help create shareholder value.

Kraken Robotics (KRKNF), closed Monday's trading session at $1.21, up 11.0092%, on 599,284 volume. The average volume for the last 3 months is 34,309 and the stock's 52-week low/high is $0.2923/$1.22.

Tungray Technologies (TRSG)

We reported earlier on Tungray Technologies (TRSG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tungray Technologies Inc. (NASDAQ: TRSG) is an engineer-to-order (ETO) company engaged in the provision of tooling and customized industrial manufacturing solutions.

The firm has its headquarters in Singapore and was incorporated in 2022, on June 1st by Wanjun Yao. It operates as part of the metal fabrication industry, under the industrials sector. The firm serves consumers in Singapore and China.

The company operates as a subsidiary of Pegasus Automation Limited. Its subsidiaries, Qingdao Tongri Electric Machines Company Limited and Qingdao Tungray Intelligent Company Limited, are specialized in the design and manufacturing of self-contained, high-frequency induction welding equipment. Its other subsidiary designs and manufactures industrial-grade direct drive and linear DC motors. Geographically, the company generates the majority of its revenue from Singapore and the rest from China.

Tungray Technologies provides customized industrial test and tooling solutions; welding equipment manufacturing; and direct drive and linear direct current motors. It also designs, develops, and manufactures non- standard equipment, such as automated assembly equipment, precision testing equipment and tooling fixtures, among others, as well as induction brazing and hardening equipment, and tooling fixtures. In addition to this, it researches, develops, and sells intelligent robots and storage equipment; and installs industrial machinery and equipment, and mechanical engineering works. The enterprise offers its services to original equipment manufacturers in the industry sectors of semiconductors, printers, electronics, and home appliances.

The firm, which recently launched its IPO, remains committed to delivering tailored industrial manufacturing solutions to key sectors while driving technological advancements and creating sustainable value for society. This may positively influence investments into the firm as well as its overall growth.

Tungray Technologies (TRSG), closed Monday's trading session at $2.7701, off by 5.7789%, on 17,492 volume. The average volume for the last 3 months is 1.472M and the stock's 52-week low/high is $2.0627/$11.78.

Aurora Cannabis Inc. (ACB)

InvestorPlace, Schaeffer's, StocksEarning, MarketClub Analysis, MarketBeat, The Street, QualityStocks, StockEarnings, Trades Of The Day, Daily Trade Alert, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Kiplinger Today, StockMarketWatch, CFN Media Group, Investopedia, CannabisNewsWire, Stock Up Featured, Profit Trends, BUYINS.NET, Early Bird, BlackSwanAlert, The Rich Investor, StreetAuthority Daily, Jim Cramer, TheoTrade, Cannabis Financial Network News, CNBC Breaking News, Inside Trading, Daily Profit, Investors Alley, Investors Underground, Market Intelligence Center, Outsider Club, Zacks, Technology Profits Daily, The Wealth Report, TheTradingReport, Top Pros' Top Picks, Tradespoon, Wall Street Window and Money and Markets reported earlier on Aurora Cannabis Inc. (ACB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

California Senate lawmakers have advanced a bill that would grant small cannabis cultivators a new license to sell directly to consumers at state-run farmers’ markets and other transient events. Additionally, the bill would allow adults to use cannabis at events that have been approved.

The bill does not, however, imply that small marijuana farmers can openly sell their goods at farmers’ markets alongside other merchants. Cannabis sales in approved locations would require certain regulatory permits from state and local authorities.

The assembly initially approved the bill in May, where it received overwhelming support before heading to the senate. The bill is now poised for a full senate vote after passing through two senate committees.

If the senate approves it, the bill will return to the assembly for approval of the senate’s amendments. One key amendment states that license holders may only offer products for sale and permit on-site consumption at temporary events organized by the state, not at other kinds of temporary gatherings.

Temporary event licenses would be issued by the Cannabis Control Department (DCC). With these permits, those 21 years of age and older would be able to purchase cannabis and consume it on-site at establishments that have local approval.

These activities require permission from local governments, and licenses would only be granted to those who meet the requirements for small-scale cannabis production. This group of growers consists of individuals who grow no more than an acre of marijuana or those who have mixed-light tier 1 or tier 2 permits, each of which has a maximum square footage requirement.

The measure expands on a 2018 California state law that authorized cannabis event permits for a limited time in locations where municipal governments have granted permission. For the first time, marijuana sales and on-site consumption were made possible by the 2018 law at gatherings such as the California State Fair. The new rule would give small-scale producers that obtain the required permits the same sales chances as licensed shops, which are now permitted to sell their products.

In parallel developments, a more comprehensive legislative proposal aimed at overhauling California’s hemp and cannabis regulations seems to have stalled. A committee in the senate failed to bring the proposal to a vote before the deadline, leaving its future uncertain.

The plan, backed by Governor Gavin Newsom, included an amendment that would have integrated hemp-derived products into the state’s licensed cannabis market. Additionally, it aimed to permit hemp farmers from other states to market their goods in California.

This new legislation breaks new ground, and many cannabis companies such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) will be watching to see if other jurisdictions also take up this approach of helping smaller cannabis growers to access the final consumers of their products.

Aurora Cannabis Inc. (ACB), closed Monday's trading session at $6.48, off by 0.4608295%, on 699,377 volume. The average volume for the last 3 months is 24.96M and the stock's 52-week low/high is $2.84/$11.50.

Alphabet Inc. (GOOGL)

The Street, InvestorPlace, Kiplinger Today, Zacks, The Online Investor, Schaeffer's, Daily Trade Alert, Investopedia, Trades Of The Day, Market Intelligence Center Alert, Money Morning, Early Bird, MarketBeat, MarketClub Analysis, StreetInsider, Uncommon Wisdom, StreetAuthority Daily, Wealth Insider Alert, Top Pros' Top Picks, Daily Profit, StrategicTechInvestor, Wyatt Investment Research, The Street Report, Wall Street Daily, The Wealth Report, TopStockAnalysts, Money and Markets, CustomerService, AllPennyStocks, Louis Navellier, MarketWatch, StocksEarning, All about trends, Investing Daily, Daily Wealth, TipRanks, ProfitableTrading, Stansberry Research, CNBC Breaking News, INO.com Market Report, Marketbeat.com, Investors Alley, INO Market Report, MarketTamer, MarketArmor.com, Market Intelligence Center, Darwin Investing Network, Trading Tips, Power Profit Trades, QualityStocks, InvestorGuide, Stock Up Featured, InsiderTrades, Options Elite, Barchart, InvestorIntel, Money Wealth Matters, DividendStocks, Cabot Wealth, Total Wealth, The Night Owl, StockEarnings, SmallCapNetwork, Daily Dividends, GorillaTrades, TheOptionSpecialist, WStreet Market Commentary, FreeRealTime, The Daily Market Alert, Insider Wealth Alert, Jon Markman’s Pivotal Point, Dynamic Wealth Report, Investiv, Investing Futures, Short Term Wealth, SmallCap Network, The Weekly Options Trader, Eagle Financial Publications, Investing Signal, Investor Guide, Trader Prep, InvestorsObserver Team, Trade of the Week, Trading Concepts, Market Authority, Average Joe Options, Investing Lab, The Motley Fool, StockMarketWatch, Smartmoneytrading, 24/7 Trader, Jim Cramer, Wealth Daily, TradingPub, Equities.com, The Wall Street Transcript, Investment House, Chaikin PowerFeed, Shah's Insights & Indictments, Financials Trends, Inside Investing Daily, Investing Breakout, Investment U, Earnings360 Newsletter, Stock Barometer, TrendAdvisor, Tradespoon, TradeSmith Daily, Traders For Cash Flow, Top Pros Top Picks, The Trading Report, The Stock Dork, RedChip, BUYINS.NET, ChartAdvisor, Profit Confidential, Lance Ippolito, Mind Over Markets, StockReport, Pennystockmania, CNBC, Contrarian Outlook, Schaeffer’s, bullseyeoptiontrading, BillionDollarClub, Beat The Street, empirefinancialresearch, Earnings360, 360 Wall Street, Day Trade Alert, Candle Stick Forum, Energy and Capital, Economic News Room, Dividend Opportunities, Energy & Resources Digest, StreetAuthority Financial, Rockwell Trading, Roundtable Roundup, SECFilings.com News, SmallCapVoice, Smart Investing Today, Smart Money Press, SmartTrading, Microcapmillionaires, Street Insider, PoliticsAndMyPortfolio.com, Summa Money, SwingTradeOnline, SystemTrading, Technology Profits Daily, Tim Bohen, Tim Sykes, wyatt research newsletter, Stock Gumshoe, Liberty Through Wealth, Greenbackers, HotStockProfits and iDigital Market reported earlier on Alphabet Inc. (GOOGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alphabet’s (NASDAQ: GOOGL, GOOG) Google, a tech giant known for its search engine and various digital services, has recently made headlines with a $250 million deal with the state of California. This agreement is designed to support newsrooms across California, providing a much-needed financial boost to the journalism industry. The industry has been struggling with financial difficulties and has seen numerous layoffs over the year. This move by Google is seen as a commitment to the media sector, highlighting the company’s involvement in areas beyond its core tech operations.

Despite the significant amount of money involved, some critics argue that the $250 million investment is not enough to tackle the extensive challenges faced by the journalism industry. They view it as a half-measure or even a cop-out, suggesting that more substantial actions are needed to address the issues thoroughly. This criticism points to the ongoing debate about the role of big tech companies in supporting journalism and whether their contributions are sufficient.

The deal also brings to light Google’s influence in the media landscape. With such a substantial investment, questions arise about the tech giant’s power and its potential impact on journalistic independence and integrity. The balance between supporting the industry financially and maintaining a healthy distance to ensure unbiased journalism is a delicate one. This situation underscores the complex relationship between the tech industry and journalism, where financial support is crucial yet fraught with concerns about influence and control.

On the financial side, Google’s stock has shown robust performance, reaching a high of $167.55 during the day. This financial health indicates Google’s capacity to make significant investments in various sectors, including journalism. The stock’s performance reflects investor confidence in Google’s business model and its strategic initiatives, such as the deal with California to support journalism. This investment not only demonstrates Google’s commitment to the media sector but also showcases its financial strength and ability to influence industries beyond technology.

To view the company’s latest earnings release, visit https://ibn.fm/1vFFk

About Alphabet Inc.

Alphabet is a collection of companies, the largest of which is Google. Larry Page and Sergey Brin founded Google in September 1998 and the company is headquartered in Mountain View, Calif. Billions of people use its wide range of popular products and platforms each day, like Search, Ads, Chrome, Cloud, YouTube and Android. For more information, visit the company’s website at www.ABC.xyz.

Alphabet Inc. (GOOGL), closed Monday's trading session at $166.16, up 0.3260476%, on 14,190,417 volume. The average volume for the last 3 months is 29,985 and the stock's 52-week low/high is $120.2057/$191.75.

CPI Card Group (PMTS)

QualityStocks, Marketbeat.com, TradersPro, MarketBeat, StockMarketWatch, FreeRealTime, StreetInsider, StockEarnings, Zacks, Top Pros' Top Picks, Rick Saddler and Hit and Run Candle Sticks reported earlier on CPI Card Group (PMTS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CPI Card Group (NASDAQ: PMTS), a payments technology company, announced the closing of the private offering by CPI CG Inc., its wholly owned subsidiary, of $285 million aggregate principal amount of its 10.000% senior secured notes due 2029 and related guarantees. CPI CG used the net proceeds from the notes offering, combined with cash on hand, to redeem all of its outstanding 8.625% senior secured notes due 2026 and to pay related fees, premiums and expenses. In addition, CPI Card Group announced entry into a $75 million secured asset based revolving facility, which replaced its existing $75 million facility.

To view the full press release, visit https://ibn.fm/zSpSG

About CPI Card Group Inc.

CPI Card Group is a payments technology company providing a comprehensive range of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service (“SaaS”) instant issuance. With a focus on building personal relationships and earning trust, the company helps its customers navigate the constantly evolving world of payments, while delivering innovative solutions that spark connections and support their brands. CPI Card Group serves clients across industry, size, and scale through its team of experienced, dedicated employees and its network of high-security production and card services facilities – located in the United States. For more information about the company, visit www.cpicardgroup.com.

CPI Card Group (PMTS), closed Monday's trading session at $28.1, off by 0.1421464%, on 10,875 volume. The average volume for the last 3 months is 8.111M and the stock's 52-week low/high is $12.65/$31.00.

Coinbase Global Inc. (COIN)

Schaeffer's, InvestorPlace, QualityStocks, MarketClub Analysis, The Street, Zacks, Prfmonline, MarketBeat, Greenbackers, Early Bird, StockEarnings, Kiplinger Today, INO Market Report, Investopedia, OTCPicks, SmallCapVoice, The Online Investor, Ceocast News, The Wealth Report, InsiderTrades, HotOTC, CoolPennyStocks, Daily Trade Alert, Trades Of The Day, StocksEarning, StockEgg, Penny Invest, Stock Stars, TradersPro, Stock Rich, FreeRealTime, CryptoCurrencyWire, Top Pros' Top Picks, BestOtc, The Stock Psycho, Top Gun, CNBC Breaking News, BullRally, Jeff Bishop, Investors Underground, HotShotStocks, BillionDollarClub, Wealth Daily, StockHotTips, bullseyeoptiontrading, FeedBlitz, Cabot Wealth, Energy and Capital, Today's Financial News, DividendStocks, Eagle Financial Publications, Smartmoneytrading, PennyTrader Publisher, MarketClub Options, Summa Money, StockRich, PennyInvest, PennyStockVille, MadPennyStocks, Profit Confidential, Louis Navellier, Stockpalooza, AlphaShark Trading, Dawn Report, Atomic Trades, wealthmintrplus, Stock Fortune Teller, WiseAlerts, wyatt research newsletter, Blaque Capital Stocks, BloomMoney, CRWEWallStreet, Standout Stocks, Round Up the Bulls, StockMister, Pennybuster, Penny Stock Rumble, AllPennyStocks, Momentum Traders, MicrocapVoice, TradingPub, InvestorsUnderground, Dynamic Wealth Report, Penny Stock Finder, Stock Traders Chat, Trading with Larry Benedict, Green Chip Stocks, Stock Analyzer, Early Investing, Wealth Whisperer and TipRanks reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Leading American financial services provider State Street is teaming up with Swiss crypto company Taurus to roll out new digital asset services. The collaboration aims to cater to the rising demand among institutional investors for opportunities in the digital asset space, including the ability to transform physical assets into tradeable digital tokens.

Institutional interest in cryptocurrencies has increased as they become more prevalent in the financial system, especially through regulated products such as exchange-traded funds (ETFs) and futures. With these new asset classes, many of these investors are trying to find strategies to diversify their portfolios and protect themselves from inflation.

Through the collaboration, State Street, which presently provides accounting and cryptocurrency fund management services, will broaden its range of services by taking custody of customers’ cryptocurrency assets and helping them to tokenize assets such as stocks and funds.

Tokenization is the process of transferring ownership rights of conventional assets into digital tokens that are stored on a blockchain. The openness and security of this user-managed decentralized technology are highly commended because it can provide more efficient and straightforward trading of these assets. For instance, BlackRock has launched a tokenized fund on the Ether blockchain, allowing investors to earn yields in U.S. dollars.

State Street’s head product officer and chief of Digital Asset Solutions, Donna Milrod, stated that the goal of the company’s new offering is to assist asset-management customers who are considering tokenizing their investments. She mentioned that the new service would be launched soon, but she did not say when it would be accessible.

Taurus and State Street’s collaboration also tackles the issue of reliable custodians for digital assets. There’s a growing inclination among organizations exploring the crypto field to protect these digital assets through established banks instead of depending on wallet or exchange providers that might have laxer security controls.

Institutional interest in cryptocurrency has increased dramatically in the wake of this year’s introduction of multiple spot Ether and Bitcoin ETFs. Prominent financial institutions, including Goldman Sachs and Morgan Stanley, made approximately $600 million in spot Bitcoin exchange-traded funds (ETF) investments during the second quarter, following the lead set by financial advisors, hedge funds and pension funds.

In June, a division of the bank, State Street Global Advisors (SSGA), submitted an application to the U.S. Securities and Exchange Commission (SEC) to register a Galaxy Asset Management (GAM) cryptocurrency fund. GAM would offer exposure to cryptocurrency businesses and exchange-traded funds, while SSGA provides administrative support.

However, plans to provide cryptocurrency custody services, where the bank would securely store clients’ crypto assets, are contingent on the SEC amending its 2022 accounting rules. The current guidelines make it prohibitively expensive for publicly traded banks to hold crypto assets for their customers.

As more players such as State Street join the likes of Coinbase Global Inc. (NASDAQ: COIN) in expanding the range of services that they offer, more retail and institutional clients are likely to be brought into the fold, and the penetration of the industry will grow.

Coinbase Global Inc. (COIN), closed Monday's trading session at $204, off by 3.5005%, on 5,437,092 volume. The average volume for the last 3 months is 3.442M and the stock's 52-week low/high is $69.63/$283.48.

Nikola Corporation (NKLA)

Green Car Stocks, Schaeffer's, StockEarnings, InvestorPlace, QualityStocks, MarketClub Analysis, StocksEarning, MarketBeat, The Street, Early Bird, Kiplinger Today, Trades Of The Day, StreetInsider, Daily Trade Alert, The Online Investor, Zacks, GreenCarStocks, Cabot Wealth, Louis Navellier, CNBC Breaking News, Wealth Insider Alert, Investopedia, MarketTamer, InvestorsUnderground, Premium Stock Alerts, INO Market Report, BillionDollarClub, Prism MarketView, Daily Profit, Outsider Club, DividendStocks, TipRanks, Earnings360, The Wealth Report, Green Energy Stocks, AllPennyStocks, StockMarketWatch and Daily Wealth reported earlier on Nikola Corporation (NKLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nikola Corporation (NASDAQ: NKLA), whose mission is to provide solutions for a zero-emissions world, has made a strategic move by inking a pivotal contract to grow its influence in the public sector. The contract, which was made with Sourcewell, one of the world’s leading cooperative purchasing organizations, emphasizes the company’s goals and commitment to expanding its influence in the electric vehicle (EV) market.

Securing this major contract was harder than it seemed. Nikola had to undergo a complex request for proposal (RFP) process to prove its dedication to compliance and top-tier service, a crucial factor in government contracts. By securing this contract, Nikola now has access to more than 50,000 public agencies through a streamlined agreement.

So, what does this mean? Well, it simplifies the procurement process for these entities, allowing them to easily go for Nikola’s zero-emissions solutions.

If you are not already familiar with it, Sourcewell, a major player since 1978, orchestrates cooperative purchasing programs to harness the collective buying power of government and nonprofit organizations. This allows the company to provide cost-effective and efficient prenegotiated agreements. In other words, Sourcewell is now the bridge connecting Nikola with a vast network of public agencies, giving Nikola a leg up in the public sector.

By this contract, Nikola will deploy innovative hydrogen fuel cell technology to different government and municipal applications. The hydrogen fuel cell technology is appealing to heavy-duty vehicles, often constrained by the limitations of battery electric systems.

So, what does this mean for the electric vehicle manufacturer?  Nikola and Sourcewell’s partnership perfectly aligns with Nikola’s expansion goals. Nikola can now tap into the extensive network of public agencies that belong to Sourcewell to capitalize on new market opportunities. Nikola’s leaders are excited about this partnership because it signifies a growing recognition of hydrogen as the better option in the transportation sector.

However, Nikola is not the only one benefiting from this agreement; Sourcewell will also. Sourcewell members can now easily access Nikola’s cutting-edge solutions, which are backed by rigorous evaluation and bidding processes. Additionally, the collaboration between the two is in line with the broader government goals of promoting clean-energy solutions. All in all, this alliance positions Nikola to outpace the competition and take charge of sustainable transportation.

Looking ahead, the partnership could also open more doors of opportunities for Nikola. The company can now tap into other sectors, including commercial transportation and logistics.

Nikola Corporation (NKLA), closed Monday's trading session at $7.38, off by 1.6656%, on 1,158,868 volume. The average volume for the last 3 months is 18.422M and the stock's 52-week low/high is $7.02/$51.00.

The QualityStocks Company Corner

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, today announced a contract worth approximately $210 million. According to the announcement, Volt Mobility, a leading United Arab Emirates ("UAE")-based commercial leasing company, has entered into a purchase agreement to acquire 3,000 Class 1 and Class 3 EV cargo vans and trucks over a 16-month period.

Mullen will receive an initial $3 million deposit within 60 days and additional payments as the EVs are delivered. The company will begin shipping the first vehicles immediately. Mullen expects to recognize approximately $210 million in revenue over the next 16 months of the agreement. Volt plans to lease these vehicles to its corporate clients based in the Middle East and the Gulf Cooperation Council ("GCC") region, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE.

"Volt is reshaping the way people and businesses move across the UAE and GCC," commented David Michery, CEO and chairman of Mullen Automotive. "This landmark agreement provides Mullen with exposure to local global transportation companies and the opportunity for utilizing Mullen EVs across the UAE and other areas of the Middle East."

To view the full press release, visit https://ibn.fm/OQtV6

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $0.3626, up 8.0775%, on 422,492,425 volume. The average volume for the last 3 months is 8,023 and the stock's 52-week low/high is $0.23/$75.00.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

A recent statement from American tech giant Google has revealed different ways the California-based company will pursue its renewable energy goals in the United STates. In a blog post published on the company's website, global head of Data Center Energy Amanda Peterson Corio, as well as Data Center energy lead Christopher Scott, discussed several ways Google can advance its clean-energy goals. The blog post announced that Google is teaming up with Swift Current Energy  and Energix Renewables to pursue its goal of achieving 24/7 clean energy on the PJM (Pennsylvania-New Jersey-Maryland) interconnection. This interconnection is responsible for coordinating electricity movement through Illinois, Delaware, Kentucky, Michigan, Maryland, New Jersey, Pennsylvania, North Carolina, the District of Columbia, Indiana, Ohio, Virginia, Tennessee and West Virginia. The tech company's partnership with Energix Renewables will allow it to tap into 1.5 gigawatts (GW) worth of solar energy from new projects in the PJM region. Furthermore, its collaboration with Swift Current Energy will enable a 299-megawatt (MW) solar project dubbed Black Diamond that won't require major grid upgrades. Both companies will also make a joint investment in Double Black Diamond, a 593 MW solar project that's poised to be the largest in the MISO (Midwest Independent System Operator) grid system. Major corporations such as Google and other consumers of huge amounts of energy could in future benefit from the decentralized energy-generation and distribution solutions that are being commercialized by many companies, such as Correlate Energy Corp. (OTCQB: CIPI).

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Monday's trading session at $0.2325, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $75.00/$.

Recent News

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF)

The QualityStocks Daily Newsletter would like to spotlightFathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF).

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), an exploration company targeting magmatic nickel sulphide discoveries to support the rapidly growing global electric vehicle market, is reporting final results from its June soil and rock geochemistry program, which was completed at the company's Gochager Lake Property. Calling the program "highly successful," the company reported that the results "clearly demonstrate that the geochemical footprint of the Gochager Lake deposit has been extended by up to four kilometers along trend (approximately two kilometers in both the NE and SW directions)." The company also completed the construction of its 20–25-person, all-season camp, which is located at the Gochager Lake project.

"The company is ecstatic with the results from this soil and rock geochemistry program," said Fathom Nickel CEO and VP exploration Ian Fraser in the press release. "Through our drilling at the historic Gochager Lake deposit over the course of the last 18 months, we have developed a clear understanding of the deposit's geochemical footprint. The combination of highly anomalous Ni-Cu-Co + chrome and magnesium in-soil, rock geochemistry results generated by pXRF, and rock assay data has expanded the Gochager Lake deposit geochemical footprint dramatically — to an area that now measures, incredibly, some 1.7 square kilometers. That's 25 times larger than the area of the historic Gochager Lake deposit. . . . We are very confident that our exacting exploration approach will continue to successfully expand the historic Gochager Lake deposit along strike and to depth, in terms of both grade and tonnage. We are also very confident of significant additional discoveries both within the now-expanded footprint and also the greater Gochager Lake property. Based on continuing results, there is clear and compelling potential for a major discovery to be had here."

To view the full press release, visit https://ibn.fm/piZ80

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (EV) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan.

Led by a management team with more than 100 years of combined mining and exploration experience, Fathom believes in a continuing bright outlook for nickel and its increasing use in the manufacturing of batteries needed for energy storage in the high-growth renewable energy and EV industries. The company’s modern approach to exploration has yielded significant new nickel discoveries.

Fathom is headquartered in Calgary, Alberta.

Projects

The Albert Lake Project

The Albert Lake Project comprises 90,460 hectares of lands located in north-central Saskatchewan, with over 80,000 hectares currently unexplored. The project is host to the historic Rottenstone Mine, a high-grade, open pit nickel sulfide past producer that was active from 1965 to 1969 and yielded ~26,000 tonnes of 3.3% Ni, 1.8% Cu, and >9 g/t Pd-Pt+Au.

The geological setting of the Albert Lake Project is within the Trans Hudson Orogeny (Corridor), which is host to numerous world-class nickel mining camps including the Thompson Nickel Belt (currently operating with more than 5 billion pounds of nickel produced since 1959), Lynn Lake (past producer) and Raglan Nickel Belt (currently operating with more than 39,000 tons of nickel produced in 2020).

The project is fully permitted. Exploration plans for 2024 include drilling a high-priority target located approximately 2km south of the historic Rottenstone Mine along with drilling other high-priority targets. Additional soil geochemistry, surface geophysical programs and geological mapping and prospecting will be performed during the summer field season.

The Gochager Lake Project

The Gochager Lake Project in northern Saskatchewan, also in the prolific Trans Hudson Corridor, was recently expanded through the addition of the contiguous Watt’s Lake property and direct staking, bringing its total land area to 22,620 hectares.

The Gochager Lake property is host to a historic resource defined by drilling in 1966-1967 consisting of 4.2 M tons grading 0.29% Ni and 0.08% Cu. Recent drilling by Fathom has defined multiple very robust off-hole borehole electromagnetic (BHEM) responses in eight of nine holes drilled in 2023 and three historic drill holes probed. There is very strong evidence of multiple, high-grade nickel-copper-cobalt steeply oriented chutes within the historic Gochager Lake Deposit.

Prior to Fathom exploration in 2023 and since 1970, exploration at the property has been limited to small drill programs in 1989-1990 and 2018. Exploration plans for 2024 include expanded surface geophysical programs, drilling and continued BHEM surveys to expand tons and increase the grade of the historic Gochager Lake deposit. Summer exploration will consist of soil geochemistry, mapping, prospecting and additional surface geophysical programs focused on identifying other Gochager-like deposits within the current land package.

Market Opportunity

Nickel plays a crucial role in clean energy technologies, and that is expected to cause demand to well outstrip supply for the foreseeable future.

With an annual market value of around $35 billion, nickel demand is projected to rise due to its intensive use in lithium-ion batteries used to power EVs. However, new discoveries of nickel sulfide deposits (currently the most reliable source for battery-grade class 1 nickel) have been rare, which could constrain class 1 nickel supply in the coming years.

According to Deloitte’s global EV forecast, total EV sales will grow from 2.5 million in 2020 to 11.2 million in 2025, reaching 31.1 million by 2030 and representing approximately 32% of the total market share for new car sales. Over the next 10 years, the EV market is projected to see a CAGR of 29%, with increased demand for nickel expected to be comparable.

Management Team

Fathom Nickel has assembled a best-in-class leadership team consisting of highly qualified industry professionals with deep knowledge and understanding of the mineral exploration industry and capital markets.

Ian Fraser, P.Geo., is CEO, VP Exploration and Co-Founder of Fathom Nickel. He has more than 35 years of experience in mineral exploration, as well as managing and implementing exploration projects in Canada and internationally. His experience includes resource interpretation and development of the Casa Berardi Gold Mine and Komis Gold Mine, as well as the Cisneros Gold Mine in Colombia.

Doug Porter, CPA, CA, CBV, is President, CFO and Director of Fathom Nickel. He is a senior financial and accounting executive with specific emphasis in resource company management. His career includes positions with Elan Coal Ltd., Altitude Resources Ltd. and StimWrx Oilfield Services Ltd.

Fathom Nickel Inc. (OTCQB: FNICF), closed Monday's trading session at $0.0332, even for the day, on 180,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0222/$0.2588.

Recent News

ECGI Holdings Inc. (OTC: ECGI)

The QualityStocks Daily Newsletter would like to spotlight ECGI Holdings Inc. (OTC: ECGI).

Many renowned luxury brands – fashion houses and watchmakers – honor their equestrian roots and the strong relationship with horses, from Rolex and Longines to Burberry, Gucci, Hermès, and Ralph Lauren

The companies, which have successfully remained in operation for decades and continue to be influenced by equestrian elements, underscore the proven potential of the luxury equestrian market to build large-scale luxury players

Beyond an equestrian influence, leading fashion houses emphasize and embody quality, unmatched craftsmanship, and innovation, qualities that ECGI Holdings and its subsidiary Pacific Saddlery have adopted

A diversified holding company, ECGI Holdings intends to cater to the growing demand for high-quality equestrian apparel through its new collection under the Allon brand, building to broader luxury sectors

In 1901, the then-45-year-old Burberry, now a renowned British luxury fashion house, ran a public competition seeking a winning entry that would become the new logo for the company. The winning entry was the equestrian knight design ("EKD"), a testimony to the company's relationship with its communities. The EKD depicted an armor-clad knight riding a horse while wielding on one hand a shield emblazoned "B" and on the other, a banner that reads ‘Prorsum' (Latin for ‘Forward') (https://ibn.fm/ogj1n).

Since then, the EKD symbol underwent several transformations, with Burberry recently reviving it under the auspices of Daniel Lee, its new creative director, as part of the company's rebranding efforts. Burberry's equestrian-inspired logo is one of a few prominent logos that feature a horse and its rider – the others being Hermès and Ralph Lauren. The long-standing equestrian histories of these luxury fashion houses and watchmakers point to the lucrativeness of their strong relationships with horses. It is this success, which transcends decades and centuries, that captured the attention and interest of ECGI Holdings (OTC: ECGI), a diversified holding company with a portfolio encompassing viticulture and luxury fashion.

ECGI Holdings Inc. (OTC: ECGI) is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating the Petite Sirah varietal, known for its bold and rich character, aligning with the growing demand for unique and high-quality wine experiences.

In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI Holdings’ commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle.

Moving forward, ECGI Holdings is focused on identifying and capitalizing on growth opportunities that align with the company’s business objectives and continuing to improve its financial structure. In 2024, ECGI Holdings was approved by Evolve — a distinguished name in vacation rental management. This partnership will transform the company’s 40-acre Lake County property into a luxurious short-term rental destination aptly named Vintner’s Caldera Ranch.

ECGI Holdings is excited about the possibilities that Vintner’s Caldera Ranch creates for shareholders and looks forward to further developments poised to unlock the value of other underutilized assets. The company believes that it is laying a solid foundation for sustained success and profitability in the years to come.

ECGI Holdings is headquartered in Irvine, California.

Operational Philosophy

ECGI Holdings has embarked on an ambitious new vision and strategic direction to build and nurture luxury brands that resonate with its core values and market aspirations. Its joint venture with Pacific Saddlery epitomizes ECGI Holdings’ strategic shift toward luxury branding, leveraging Pacific Saddlery’s tangible and established market presence in equestrian products.

This transition will also allow ECGI Holdings to explore new pathways to monetize its underutilized assets, including the company’s vineyard. A key highlight of the company’s future outlook is the debut of Pacific Saddlery’s new mobile retail boutique at specific equestrian events in 2024. This innovative venture represents a significant step in ECGI Holdings’ strategy to enhance brand visibility and engage directly with the company’s target market.

In addition, the Vintner’s Caldera Ranch development marks a significant step in advancing the company’s strategy to revitalize and leverage underutilized assets. Vintner’s Caldera Ranch is set against the backdrop of Lake County’s breathtaking scenery, offering an exclusive getaway experience that blends natural beauty with luxury. Choosing Evolve is a strategic move to ensure that Vintner’s Caldera Ranch not only meets but exceeds the high standards of service that luxury guests expect.

Evolve’s expertise in maximizing rental potential and delivering exceptional guest experiences is crucial to the company’s vision of making Vintner’s Caldera Ranch a preferred choice for discerning travelers. With this venture, ECGI Holdings is not only expanding its footprint within the luxury rental marketplace, but also contributing to the local economy and enhancing the appeal of Lake County as a tourist destination.

The company’s focus remains steadfast on strategic growth, operational excellence and customer satisfaction.

Market Outlook

A report from Grand View Research, a global market research and consulting company, estimated the value of the worldwide luxury brands market at $366.23 billion in 2023 and projects the market to grow to a value of $580.43 billion by 2030, achieving a CAGR of 6.8% over the forecast period.

Rising disposable income and wealth in various regions of the world, particularly in emerging markets such as China and India, have propelled the growth of the market, according to the report.

Younger consumers, such as millennials and Generation Z, are increasingly entering the luxury market, driving demand for more contemporary and experiential luxury offerings. The rise of social media and influencer marketing has greatly impacted the visibility and desirability of luxury products, the report states.

Management Team

Jamie Steigerwald is CEO of ECGI Holdings, Inc. He is a successful entrepreneur with over 30 years of experience. Most recently, he was COO of Sugarmade Inc. (OTC: SGMD), a California cannabis real estate, cultivation, manufacturing and services company. He is the owner of SwiftLead, an Orange County web marketing, design and development company. He previously was COO for First USA Home Loans, a retail mortgage lender, and co-founder and President of SwiftLead Software, a mortgage lead tracking system.

Nick Collins is CEO at Pacific Saddlery. He brings over 25 years of expertise in equestrian luxury goods. He previously founded Rolling Meadows and created the Allon Equestrian and Renard et Cheval apparel brands. He was instrumental in creating and launching Kaval.com, an online equestrian apparel and accessories site.

ECGI Holdings Inc. (OTC: ECGI), closed Monday's trading session at $0.0024, even for the day, on 49,999 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0016/$0.0149.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Upstream, a MERJ Exchange stock market and global trading app, is the next-generation market for maximizing liquidity and investor access, notes a recent blog. According to the blog, Upstream solves the problems of international shareholders facing difficulty depositing shares for secondary trading as well as overseas investors struggling to buy stock on current exchanges. Upstream enables issuers listed on both U.S. and international stock exchanges to dual list their shares, thereby reaching investors outside of their primary markets. 

Upstream has a simple onboarding process, the blog observes, and gives retail investors the ability to trade stock using an app from anywhere in the world. "Unlike traditional stock exchanges, Upstream eliminates traditional middlemen, payment for order flow, and market manipulation techniques, leveraging smart-contract technology to ensure transparency and fairness," the blog states. "Trading is peer-to-peer, 20 hours a day, five days a week with instant settlement. All of these features work to increase liquidity potential from international retail traders."

To view the full blog, visit https://ibn.fm/PgEHX

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).

The company has released key corporate and business updates and Q2 2024 financial results

Clinical trials for both Alzheimer's and Parkinson's studies yielded encouraging data for lead compound buntanetap

Buntanetap in combination with GLP-1 agonist dulaglutide Trulicity(R) showed increased potential to synergistically enhance cognition

The company has obtained a patent and begun manufacturing of a new crystalline form of buntanetap, with improved properties

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease ("AD") and Parkinson's disease ("PD"), offered key business updates and announced financial results for the second quarter ended June 30, 2024. The company reported productive recent months, with encouraging data on lead compound buntanetap's performance in two pivotal studies, according to Maria Maccecchini, Ph.D., Founder, President, and CEO (https://ibn.fm/hc6L4).

Annovis Bio Inc. Overview

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as AD and PD. Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach addresses both the cognitive decline in AD and the motor dysfunction in PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly known as Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a 3.3 point improvement compared to 0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating buntanetap’s mechanism of action.

Similarly, in the recently completed Phase III study of buntanetap in patients with early PD, buntanetap significantly improved disease-related daily non-motor and motor functions in Parkinson’s patients who had a diagnosis over 3 years as well as improved cognition in all PD patients. It further underscores buntanetap’s potential as a transformative therapy.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050​ (Alzheimer’s Association)​​ (Republican Policy Committee)​. Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease​ (SingleCare)​.

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050​​. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Recent Phase III data in Parkinson’s Disease patients demonstrates significant improvements in motor and cognitive functions.
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

  • Maria L. Maccecchini, Ph.D. – Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.
  • Cheng Fang, Ph.D. – Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.
  • Michael Christie, Ph.D. – VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.
  • Melissa Gaines – Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.
Recent Achievements

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Investment Considerations
  • Unique Market Position: Annovis Bio is uniquely positioned as the only company developing a drug for both AD and PD that inhibits multiple neurotoxic proteins simultaneously.
  • Strong Clinical Results: Buntanetap’s Phase II/III data shows significant cognitive improvement in early AD patients, and the recent Phase III data in PD patients further validates its broad therapeutic potential.
  • Strategic Growth Plans: With recent successful trial results, Annovis Bio is poised for future growth, supported by strong patent protections and upcoming clinical trials.
  • Significant Market Need: As the prevalence of neurodegenerative diseases continues to rise, the demand for effective treatments like buntanetap remains critical.

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Annovis Bio Inc. (NYSE: ANVS), closed Monday's trading session at $9.67, off by 0.2063984%, on 125,022 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.53/$22.49.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, has closed on an exercise of certain existing warrants. The exercise consisted of purchasing 505,502 shares of the company's common stock at a reduced exercise price of $4.60 per share. The company also issued new warrants. According to the announcement, gross proceeds from the exercise of the existing warrants totaled an estimated $2.3 million before fees and deductions. The company plans to use the funds from the transaction for working capital and general corporate purposes, including the continued rollout of its Evolve(R) product line. H.C. Wainwright acted as the exclusive placement agent for the transaction.

To view the full press release, visit https://ibn.fm/cPNOO

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.

ContraPest®

SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Monday's trading session at $3.7, off by 9.7561%, on 65,224 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.35/$81.60.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

Electronic monitoring solutions company SuperCom Ltd. provides a suite of products and services to justice system officials worldwide, promoting public safety through the secure tracking of individuals who require supervision

SuperCom's PureSecurity technology has the ability to serve a wide variety of tracking purposes but is specifically targeting electronic monitoring of offenders, including domestic violence cases, drug rehabilitation services, and probation orders

The company recently reported its second quarter and first half financial results, noting growth across multiple metrics, including record profits following a 65.2 percent surge in gross profit and 20.4 percent growth in gross profit margin

SuperCom's EBITDA grew by 83 percent in the quarter, and by 182 percent for the first half of the year

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, is announcing that it has secured new electronic monitoring contracts with multiple Sheriff agencies across West Virginia. These contracts leverage SuperCom's innovative PureOne suite to provide robust monitoring solutions in rural areas. According to the announcement, the contracts are already generating recurring revenue, solidifying SuperCom's footprint in the U.S. market, particularly in rural regions where robust and reliable monitoring solutions are crucial.

"We are excited to partner with Sheriff agencies across West Virginia to bring our cutting-edge PureOne technology to their communities. These contracts highlight our dedication to innovation and our ability to meet the diverse needs of law enforcement agencies, especially in challenging environments," said Ordan Trabelsi, President and CEO of SuperCom.

To view the full press release, visit https://ibn.fm/oW6tf

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Monday's trading session at $3.31, off by 7.7994%, on 244,064 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.93/$22.60.

Recent News

HealthLynked Corp. (OTCQB: HLYK)

The QualityStocks Daily Newsletter would like to spotlightFathom HealthLynked Corp. (OTCQB: HLYK) .

Any business in the healthcare sector seeking to improve customer experience, popularly known as CX, may benefit from using health technology. Data from Forrester Research shows that 6% of brands that took part in the 2023 U.S. Customer Experience rankings saw increases in quality of customer experiences. 8×8's chief technology officer, Bryan Martin, believes this may be because brands aren't investing in processes and tools to enhance customer experiences. This enables personalized experiences in which an agent obtains detailed data specific to a consumer. For instance, it may have information about which airports consumers often fly out of as well as meals they prefer. This makes for easier communication while also allowing any requests made by customer services to be resolved quickly and proactively. Tools for consumer-relationship management can also offer context for consumer calls, helping deliver better and more personalized experiences. Companies such as HealthLynked Corp. (OTCQB: HLYK) look poised to further deepen the role that Big Data plays in the health sector. It remains to be seen how quickly the different players in this space take up these innovations.

HealthLynked Corp. (OTCQB: HLYK) is at the forefront of a transformative movement in healthcare, utilizing its extensive collection of health data to improve care for all. With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries.

HealthLynked Corp. App

In addition to these capabilities, HealthLynked provides a user-friendly platform for booking healthcare appointments, similar to how OpenTable operates for restaurant reservations. This feature allows patients to conveniently book appointments with healthcare providers across the country, including options for telemedicine consultations, enhancing accessibility and efficiency in healthcare service delivery.

Strategically headquartered in Naples, Florida, HealthLynked operates through three primary divisions: Health Services, Digital Healthcare, and Medical Distribution. Each division supports the company’s mission to revolutionize patient care and health management. Positioned as a potential leader in healthcare AI, HealthLynked is dedicated to shaping the future of the industry over the next 20 years, driving significant advancements in healthcare accessibility and effectiveness through innovation and technology.

HealthLynked Corp. Reach

Strategic Initiatives and Operational Highlights

The company’s commitment to enhancing global health is evident in its dual goals: transforming healthcare through advanced technology and creating a patient-centric network that accelerates medical discoveries and the development of disease cures.

HealthLynked’s intellectual property portfolio is robust and strategically developed to enhance healthcare delivery and management. In March 2023, HealthLynked was granted a patent for a groundbreaking healthcare-specific wireless access point, known as the “Patient Access Hub.” This technology significantly improves the efficiency of healthcare practices by enabling real-time monitoring of patient flow within facilities. It intelligently determines patients waiting in exam rooms and calculates wait times, alongside other critical practice metrics. This system not only enhances patient experience by reducing unnecessary wait times but also optimizes resource allocation within healthcare settings.

Additionally, in October 2023, HealthLynked filed a patent application for its advanced AI program, ARI (Augmented Real-time Interface). ARI acts as a virtual doctor for patients, capable of performing medical intake, booking appointments, and providing personalized medical recommendations based on a patient’s medical history. By integrating these tasks, ARI streamlines the healthcare process, reducing the administrative burden on healthcare providers and ensuring that patients receive timely and tailored healthcare advice. This AI-driven interface enhances the accessibility and personalization of healthcare, embodying HealthLynked’s commitment to leveraging technology for better health outcomes. The company recently launched HealthLynked 3.2.0, an advanced version of its application, incorporating telemedicine, AI-driven personal healthcare guidance, and remote patient monitoring – setting a new standard in healthcare technology.

Market Position and Future Outlook

According to Facts and Figures Research, a research and consulting firm, the global market for patient-centric healthcare applications is projected to reach $41.6 billion by 2030, growing at a CAGR of 18.77% from 2022. HealthLynked’s offerings align perfectly with this expansive market opportunity, especially with increasing demands for digital health solutions and data management in healthcare.

HealthLynked’s strategic direction, spearheaded by its seasoned management team, is designed to leverage these market dynamics, enhancing patient engagement and healthcare efficiency on a global scale.

Management Team

Michael T. Dent, M.D., Founder, CEO, and Chairman, brings extensive experience from his foundational role at NeoGenomics and leadership in various healthcare and technology sector companies.

David Rosal, CFO, with previous senior roles at Teradata and McDonald’s Corporation, brings a wealth of expertise in financial and business integration strategies essential for growth and operational efficiency.

Chris Hall, CTO, with a strong background in global technology development from his time at Siemens and several patents to his name, is instrumental in driving the innovation and technological advancement at HealthLynked.

Bill Crupi, Operations Manager, has a proven track record in streamlining operations and enhancing productivity across multiple sectors within the healthcare industry. His expertise is crucial in maintaining the operational excellence that HealthLynked is known for.

Michael Paisan, Director of Investor Relations, leverages his extensive experience in finance and communications to enhance HealthLynked’s relationships with investors and stakeholders, ensuring transparent and effective communication of the company’s value and growth strategy.

Gagan Babber, Manager of Software Development, oversees the HealthLynked development teams based in the U.S. and India. With a robust background in engineering and software development, he plays a critical role in guiding the technological direction of HealthLynked’s products. His expertise in developing scalable, innovative software solutions is essential for driving the company’s technical initiatives forward and ensuring that HealthLynked stays at the forefront of digital healthcare technology.

HealthLynked Corp. (OTCQB: HLYK), closed Monday's trading session at $0.052, off by 4.059%, on 18,532 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.033/$0.0999.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria, a global innovator in drug delivery platforms, just reported positive results from its applied research program conducted in collaboration with the National Research Council of Canada ("NRC")

The study's objective was to examine the molecular properties of semaglutide, processed with its patented DehydraTECH(TM) technology, comparing it to Rybelsus(R), the commercially available alternative

Lexaria's DehydraTECH demonstrated that semaglutide can be efficiently released in a simulated gastric fluid environment, without the use of salcaprozate sodium ("SNAC") ingredient chemistry

This milestone moves the company closer to the diabetes treatment market, projected to hit $153.98 billion in value by 2032

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released findings from its applied research program that sought to evaluate the mode of action facets of its patented DehydraTECH(TM) technology and the glucagon-like peptide 1 ("GLP-1") drug, semaglutide. The program was conducted in conjunction with the National Research Council of Canada ("NRC"), with the management terming the findings as "positive" (https://ibn.fm/sVTtW).

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Monday's trading session at $2.9, off by 4.2904%, on 133,276 volume. The average volume for the last 3 months is 208,615 and the stock's 52-week low/high is $0.844/$6.85.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

A long-term preclinical study of Alzheimer's Disease ("AD") drug candidate INM-901 included four groups: untreated disease-free, INM-901-treated disease-free, placebo-treated Alzheimer's Disease, and INM-901-treated Alzheimer's Disease at two dosing levels

The results showed that INM-901-treated AD groups displayed behavior trends similar to the untreated disease-free group, with a clear dose response observed in most assessments

The drug has also shown a reduction in neuroinflammation and enhancement of neuronal function, with molecular data supporting behavioral study observations

InMed Pharmaceuticals (NASDAQ: INM), a biopharmaceutical company focused on developing proprietary small molecule drug candidates for diseases with high unmet needs, has announced promising outcomes from a long-term preclinical study of its Alzheimer's Disease ("AD") drug candidate, INM-901. These new findings confirm and expand upon results from a previous short-term pilot study (https://ibn.fm/eASUI).

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.

Manufacturing

The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Monday's trading session at $0.3812, off by 4.1489%, on 3,058,986 volume. The average volume for the last 3 months is 7.109M and the stock's 52-week low/high is $0.1207/$2.08.

Recent News

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 8th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions of the Americas. The company proactively took cost-saving measures months ago to lower expenses and increase production across its portfolio of gold assets, driving some production costs below industry averages. Gold and copper prices, already in an upswing, are forecast to enter an explosive uptrend over the next couple years. Drawing from its experience, McEwen Mining planned, prepared and laid the groundwork to capitalize on this emerging opportunity.

The company currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, based on trends in earnings estimate revisions and EPS surprises. Seldom is management so aligned with investors’ interests and committed to the company’s success. With a combined investment of over $220 million, CEO Rob McEwen holds a 17% ownership stake in McEwen Mining and a 13% ownership in McEwen Copper. Acclaimed in the mining industry, McEwen founded Goldcorp, where he increased the company’s market capitalization 160 times – from $50 million to over $8 billion. That same vision and tenacity led MUX in creating McEwen Copper.

For McEwen Mining shareholders, beyond the company’s exposure to gold upsurges, its 47.7% stake in McEwen Copper is expected to be a blockbuster, turbocharging MUX by creating the world’s next prolific copper unicorn.

McEwen Copper

With continuous industrial need, new critical demand for copper is rapidly emerging, increasingly driven by the green energy transition. The price of copper rose from a low of about $2 per pound in 2020 to over $4.60 per pound in May 2024, and strong demand is expected to intensify. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global forecasts annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining owns a 47.7% equity stake in McEwen Copper, the holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which is ranked the 8th largest undeveloped copper deposit in the world. Current copper resources at Los Azules are estimated at 10.9 billion pounds at a grade of 0.40% Cu (Indicated category) and an additional 26.7 billion pounds at a grade of 0.31% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, USA, called Elder Creek.

In a 2023 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 27-year life, producing an average of 322 million lbs. of copper cathode annually, at a cash cost of $1.07 per lb. of copper, in the lowest quartile of the copper cost curve. The project could ultimately become an even larger mine with a longer life, since the extent of mineralization has not been fully assessed on the property.

The project’s 2023 PEA presents a distinctly different development strategy from a prior PEA published in 2017. By proposing a heap leach project using solvent extraction-electrowinning instead of the previously detailed mine with a conventional mill and flotation concentrator, McEwen Copper aims to decrease its environmental footprint and reduce permitting risk, albeit with a lower overall copper recovery, slightly higher unit costs and a delay in immediate cashflow due to extended leach cycles.

After securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC, McEwen Copper closed its non-brokered, private placement offering of $82 million in August 2022. Shortly after, in February 2023, Nuton agreed to invest an additional $30 million into McEwen Copper, and in October 2023, Nuton once again expanded its stake, investing an additional $10 million to bring its ownership position in McEwen Copper to 14.5%.

“We are extremely pleased to have Nuton’s strong continued participation in McEwen Copper,” Rob McEwen stated in a news release. “Together we are exploring new technologies that save energy, water, time and capital in the pursuit of delivering green copper to Argentina and the world, a product that will contribute to the electrification of transportation and the protection of our atmosphere.”

Also in February 2023, FCA Argentina S.A., a subsidiary of Stellantis N.V., one of the world’s leading automakers, invested ARS $30 billion in McEwen Copper. In October 2023, Stellantis invested an additional ARS $42 billion, bringing its current stake in McEwen Copper to 19.4%.

“We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” Rob McEwen said of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that can achieve net-zero carbon emissions by 2038.”

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project, with a Feasibility Study planned for Q1 2025. MUX strategically reduced its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver assets.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release.

McEwen Mining issued 2024 guidance for its cash cost/oz at the Fox Complex of $1,225-1,325 on annual production of 40,000-42,000 GEOs. Fox Complex produced 44,450 GEOs in 2023, which was within the company’s guidance range.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have yielded over 1,000,000 ounces of gold to date. Also, the complex includes the Grey Fox and Stock deposits that have over 1,800,000 ounces in gold resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, with a total gold content currently estimated at over 300 million ounces.

In 2024, MUX commenced development of underground ramp access to the Stock orebodies at the Fox Complex. This development will become the primary source of feed following the completion of mining the Froome deposit in 2026. As part of the future mining sequence initiative, the company has already reported a 31% year-over-year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with confirmation of good grading structures plunging to depth. It has also identified Stock East as a potential new near-term source of future revenue.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine, located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure, 25 miles south of Nevada Gold Mines, a Barrick-Newmont joint venture, part of the Cortez-Goldrush complex. This complex contains estimated reserves and resources of over 50 million gold ounces, with an annual production of 1,000,000 gold ounces.

Gold Bar had been mined between 1991 and 1994, producing 134,000 gold ounces. A new facility was built by MUX in 2019. Gold Bar accounted for 42,700 GEOs in 2023, within the company’s guidance for the year. For 2024, McEwen Mining issued guidance of 40,000-43,000 at a cash cost of $1,450-1,550. The first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program.

Notably, in April 2024, McEwen Mining announced its entry into a definitive agreement and plan of merger with Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS) in a transaction valued at roughly $18.8 million. The merger with Timberline is expected to augment McEwen’s existing portfolio of development and exploration projects in Nevada, leveraging synergies between Timberline’s projects and the Company’s Gold Bar mine.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX began operating it as an open pit, heap leach mine in 2013, which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. Due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018 and residual heap leaching followed until mid-2022. The redevelopment plan envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material, then transition to open pit mining and processing of the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to begin in the second half of 2024.

San José Mine

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine, located in Santa Cruz province, Argentina, encircling Newmont’s prolific Cerro Negro (approx. 300,000 gold ounces produced in 2023). This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 296 gpt silver and 5.4 gpt gold.

Exploration is continuing to extend high-grade veins and discover new veins at the complex. San José’s drilling programs to define additional resources and reserves have a long history of success due to a high vein density, aided by good geophysical response from hidden veins.

Production guidance for 2024 for MUX’s 49% interest is 50,000-60,000 GEOs. As a minority shareholder in the mine, MUX equity accounts for its investment in San José, and receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks suffered significant losses in the wake of the COVID-19 pandemic. However, this has turned, and many analysts now forecast a gold bull market in 2024 and beyond.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director of Operations for America and Mexico. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Monday's trading session at $9.49, up 0.1054852%, on 402,897 volume. The average volume for the last 3 months is 611,609 and the stock's 52-week low/high is $5.92/$12.50.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.